Abstract

Usha Adiga*

DOI : http://dx.doi.org/10.13005/ojc/390402

Recurrent unprovoked seizures are a hallmark of epilepsy, a chronic neurological condition caused by momentary changes in the way cortical neurons conduct electricity. Epilepsy patients have been treated with more than 20 anti-epileptic medicines (AEDs) to control their seizures, but one-third of them are resistant to the drugs. The pharmacological treatment of epilepsy frequently involves therapeutic drug monitoring (TDM), although the plasma levels of various AEDs do not always correspond well with the doses and/or the therapeutic or harmful effects of the medications. The genetic polymorphisms of numerous enzymes involved in the metabolism of these medications may be to blame for this. The study's goal was to examine UGT1A6 and UGT2B7 gene polymorphisms using bioinformatics methods.

Bioinformatics; Polyphen; SIFT; UGT gene

[ View HTML Full Text]